Ekso Bionics to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference
September 07 2021 - 4:04PM
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in
exoskeleton technology for medical and industrial use, today
announced that management will participate in a fireside chat at
the H.C. Wainwright 23rd Annual Global Investor Conference held on
September 13 - 15, 2021.
The fireside chat will be available to view
on-demand as of 4:00 AM PT / 7:00 AM ET, Monday, September 13, 2021
throughout the entirety of the conference and on the investor
section of the Company’s website at www.eksobionics.com, or by
clicking here.
About Ekso
Bionics® Ekso Bionics® is a leading
developer of exoskeleton solutions that amplify human potential by
supporting or enhancing strength, endurance, and mobility across
medical and industrial applications. Founded in 2005, the Company
continues to build upon its industry-leading expertise to design
some of the most cutting-edge, innovative wearable robots available
on the market. Ekso Bionics is the only exoskeleton company to
offer technologies that range from helping those with paralysis to
stand up and walk, to enhancing human capabilities on job sites
across the globe. Ekso Bionics is headquartered in the San
Francisco Bay Area and is listed on the Nasdaq Capital Market under
the symbol “EKSO.” For more information, visit: www.eksobionics.com
or follow @EksoBionics on Twitter.
Investor Contact:David
Carey212-867-1768investors@eksobionics.com
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Sep 2023 to Sep 2024